Statement From Dr. Reddy’s Laboratories Ltd.’s Regarding The Receipt Of Temporary Restraining Order (TRO) For Esomeprazole Capsules

HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories (NYSE: RDY) in a statement issued today said that it has been made aware of an order passed by the District Court of Delaware, USA, granting a Temporary Restraining Order (TRO) with immediate effect on sales, delivery, transfer, or other disposition of its generic esomeprazole product in the US market.

Help employers find you! Check out all the jobs and post your resume.